Back

It is time to reconsider aspirin as a routine therapy for secondary prevention after STEMI - PRO.(Via ZOOM)

4 March 2018 (14:45 - 15:00)
Organised by:
Congress Presentation Part of: Great debate on STEMI: current controversies on antiplatelet management after the acute phase Acute Coronary Syndromes: Post-Infarction Period Open Access Acute Cardiovascular Care 2018

About the speaker

Photo
Professor Pascal Vranckx

Heart Centre Hasselt, Hasselt (Belgium)

9 More presentations in this session

Presentation thumbnail
Risk scores are helpful for defining optimal DAPT duration - PRO.
Professor S. De Servi (Sesto San Giovanni, IT)
Slides Video
Presentation thumbnail
Risk scores are helpful for defining optimal DAPT duration - CONTRA.
Professor A. Budaj (Warsaw, PL)
Slides Video
Presentation thumbnail
Risk scores are helpful for defining optimal DAPT duration - Rebuttal PRO.
Professor S. De Servi (Sesto San Giovanni, IT)
Video
Presentation thumbnail
Risk scores are helpful for defining optimal DAPT duration - Rebuttal CONTRA.
Professor A. Budaj (Warsaw, PL)
Presentation thumbnail
Risk scores are helpful for defining optimal DAPT duration: Chairpersons conclusion.

Access the full session

Session thumbnail
Great debate on STEMI: current controversies on antiplatelet management after the acute phase

The Event

Event poster

Acute Cardiovascular Care 2018

4 March 2018 14:45 CET